Log In
BCIQ
Print this Print this
 

ASP6537

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionSelective cyclooxygenase-1 (COX-1) inhibitor
Molecular Target Cyclooxygenase-1 (COX-1)
Mechanism of ActionCyclooxygenase (COX) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationCognitive dysfunction
Indication DetailsImprove cognitive function in CNS disorders
Regulatory Designation
PartnerCardeus Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/04/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today